## STNE: StoneCo Ltd. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 1.08 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-12.0% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($13.10)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 7 |

**Top Holders:**
- Madrone Advisors, LL: 9.4% (0.0%)
- Blackrock Inc.: 8.1% (-12.4%)
- Atmos Capital Gestao: 3.3% (-1.7%)
- Ninety One UK Ltd: 3.1% (+536.8%)
- Point72 Asset Manage: 2.8% (-22.4%)

### Key Risks

1. High beta (1.85) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Momentum deterioration: MRS_20 falling (-12.0% 5d) with bearish MACD, trend may be turning.
3. Near-term weakness: 14.7% below SMA50 despite long-term uptrend.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.08 suggests fair value with growth premium. Forward P/E 1.3x attractive for 20% earnings growth. Institutional flow bullish (2 buying vs 7 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $4.0B |
| Beta | 1.85 |
| 52W Range | $7.72 - $19.95 |
| Short Interest | 6.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.08 |
| Forward P/E | 1.3 |
| Current P/E | 1.6 |
| YoY Growth | 20.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 2.5% to -9.5% (-12.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 13.5pp (needs >4.0% for momentum thesis). AM_20 at -7.6% indicates price below own 20MA trend. Underperforming sector by 10.7pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.01x) but short-term weakness (below SMA20).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -9.49% (CS: 2) | Weak |
| RSI_14 | 37.8 | Neutral |
| MACD Histogram | -0.06 | Bearish |
| vs SMA20 | 0.924x | Below |
| vs SMA50 | 0.853x | Below |
| vs SMA200 | 1.012x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $14.88
- **Stop Loss:** $13.10 (12.0% risk)
- **Target:** $18.44 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 674
- **Position Value:** $10,029.12
- **Portfolio %:** 10.03%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

### Earnings

**Next:** 2026-03-18 (Est: $2.76)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.34 | $2.51 | +7.3% |
| 2025Q2 | $2.05 | $2.33 | +13.4% |
| 2025Q1 | $1.85 | $1.97 | +6.3% |
| 2024Q4 | $1.96 | $2.26 | +15.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*